Virtual Medicinal Product (VMP) - Agalsidase beta 35mg powder for solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Agalsidase beta 35mg powder for solution for infusion vials Start Date 13-01-2009 End Date
Previous Name Previous Name Agalsidase beta 35mg powder for solution for injection vials Start Date 05-09-2005 End Date 12-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder for solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A16AB04
BNF Start Date End Date
Current BNF 09080100 Start Date 04-04-2022 End Date
Previous BNF 09080100 Start Date 05-09-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
41758011000001108 09-05-2023
407801001 08-09-2005 08-05-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Agalsidase beta Based on Ingredient Substance 35 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial